Cardiovascular Disease

Healio Pulmonology has compiled the top news on asthma posted in 2022.

Greater eGFR variability predicts an increased risk of death, dementia, disability and CVD events among older and healthy adults, according to data published in Kidney Medicine.

PHILADELPHIA — Opioid use in rheumatoid arthritis demonstrates a nearly two-fold increased risk for venous thromboembolism vs. NSAIDs, according to data presented at ACR Convergence 2022.

PHILADELPHIA — Patients who started TNF inhibitors earlier in their ankylosing spondyloarthritis disease course, vs. no initiation, have a higher risk for cardiovascular events, according to data presented at ACR Convergence 2022.

Supplementation of certain micronutrients benefited cardiometabolic health, but others did not, according to a systematic review and meta-analysis.

Social and economic factors have the greatest impact on COVID-19 outcomes, including an “epidemic” of CV diseases and hospitalizations, and social determinants of health must be addressed to counter disparities, according to a speaker.

CVD risk increases with the severity of nonalcoholic fatty liver disease, and both CV and liver events are “highly related” to the degree of hepatic fibrosis present, according to a speaker.

PHILADELPHIA — Making sense of real-world data and black-box warnings associated with Janus kinase inhibitors can be challenging for rheumatologists hoping to prescribe these medications, according to a presenter at ACR Convergence 2022.

Adults with nonalcoholic fatty liver disease and severe obesity have a lower risk for cardiovascular disease if they undergo bariatric surgery vs. those who do not have surgery, according to study findings published in JAMA Network Open.

In a recent study, Mexican American adults and non-Hispanic Black adults in the United States had an overall greater prevalence of hypertension, obesity and diabetes mellitus compared with white adults and Asian adults.